372 related articles for article (PubMed ID: 32271189)
41. Image analysis of proliferating cell nuclear antigen expression and immunohistochemical profiles in renal cell carcinoma associated with acquired cystic kidney disease: comparison with classic renal cell carcinoma.
Khurana KK; Truong LD; Verani RR
Mod Pathol; 1998 Apr; 11(4):339-46. PubMed ID: 9578084
[TBL] [Abstract][Full Text] [Related]
42. Chromophobe renal cell carcinoma and 'capsulomas' with acquired cystic disease of the kidney in a long-term hemodialysis patient.
Nishihara K; Shomori K; Nagashima Y; Kuroda N; Nagamatsu H; Ito H
Int J Urol; 2008 Jun; 15(6):543-5. PubMed ID: 18489645
[TBL] [Abstract][Full Text] [Related]
43. Cytologic findings of acquired cystic disease-associated renal cell carcinoma: a report of two cases.
Rivera M; Tickoo SK; Saqi A; Lin O
Diagn Cytopathol; 2008 May; 36(5):344-7. PubMed ID: 18418849
[TBL] [Abstract][Full Text] [Related]
44. Renal cell carcinoma with intratumoral calcium oxalate crystal deposition in patients with acquired cystic disease of the kidney.
Rioux-Leclercq NC; Epstein JI
Arch Pathol Lab Med; 2003 Feb; 127(2):E89-92. PubMed ID: 12562261
[TBL] [Abstract][Full Text] [Related]
45. Renal cell carcinoma with rhabdoid features.
Gökden N; Nappi O; Swanson PE; Pfeifer JD; Vollmer RT; Wick MR; Humphrey PA
Am J Surg Pathol; 2000 Oct; 24(10):1329-38. PubMed ID: 11023094
[TBL] [Abstract][Full Text] [Related]
46. Clinicopathological features and CD57 expression in renal cell carcinoma in acquired cystic disease of the kidneys: with special emphasis on a relation to the duration of haemodialysis, the degree of calcium oxalate deposition, histological type, and possible tumorigenesis.
Enoki Y; Katoh G; Okabe H; Yanagisawa A
Histopathology; 2010 Feb; 56(3):384-94. PubMed ID: 20459538
[TBL] [Abstract][Full Text] [Related]
47. GATA3 as a valuable marker to distinguish clear cell papillary renal cell carcinomas from morphologic mimics.
Mantilla JG; Antic T; Tretiakova M
Hum Pathol; 2017 Aug; 66():152-158. PubMed ID: 28705707
[TBL] [Abstract][Full Text] [Related]
48. Tumor of the kidney associated to acquired cystic renal disease.
Zehani A; Smichi I; Chelly I; Nouira Y; Haouet S; Kchir N
Tunis Med; 2017 Feb; 95(2):156-157. PubMed ID: 29424881
[No Abstract] [Full Text] [Related]
49. Imaging of acquired cystic disease-associated renal cell carcinoma by contrast-enhanced ultrasonography with perflubutane microbubbles and positron emission tomography-computed tomography.
Ishikawa I; Morita K; Hayama S; Nakazawa T; Araki I; Higashi K; Miyazawa K; Suzuki K; Nojima T
Clin Exp Nephrol; 2011 Feb; 15(1):136-40. PubMed ID: 20824295
[TBL] [Abstract][Full Text] [Related]
50. [Clinicopathological characteristics of fumarate hydratase-deficient renal cell carcinoma].
Zhang W; Chu J; Zou YW; Jiang YX; Wei ZM; Zhong DC; Liu Y; Li YJ; Yu WJ
Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):120-126. PubMed ID: 30695864
[No Abstract] [Full Text] [Related]
51. Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.
Amin MB; Corless CL; Renshaw AA; Tickoo SK; Kubus J; Schultz DS
Am J Surg Pathol; 1997 Jun; 21(6):621-35. PubMed ID: 9199639
[TBL] [Abstract][Full Text] [Related]
52. Characterizing the impact of lymph node metastases on the survival outcome for metastatic renal cell carcinoma patients treated with targeted therapies.
Kroeger N; Pantuck AJ; Wells JC; Lawrence N; Broom R; Kim JJ; Srinivas S; Yim J; Bjarnason GA; Templeton A; Knox J; Bernstein E; Smoragiewicz M; Lee J; Rini BI; Vaishampayan UN; Wood LA; Beuselinck B; Donskov F; Choueiri TK; Heng DY
Eur Urol; 2015 Sep; 68(3):506-15. PubMed ID: 25524810
[TBL] [Abstract][Full Text] [Related]
53. The prognostic value of cyclin D1 in renal cell carcinoma.
Lima MS; Pereira RA; Costa RS; Tucci S; Dantas M; Muglia VF; Ravinal RC; Barros-Silva GE
Int Urol Nephrol; 2014 May; 46(5):905-13. PubMed ID: 24242739
[TBL] [Abstract][Full Text] [Related]
54. Collecting duct carcinoma with acquired cystic disease of the kidney in a long-term hemodialysis patient.
Sakura M; Masuda H; Saito K; Koga F; Kawakami S; Kihara K
Int J Urol; 2008 Jan; 15(1):93-5. PubMed ID: 18184183
[TBL] [Abstract][Full Text] [Related]
55. CAIX and pax-8 Commonly Immunoreactive in Endolymphatic Sac Tumors: A Clinicopathologic Study of 26 Cases with Differential Considerations for Metastatic Renal Cell Carcinoma in von Hippel-Lindau Patients.
Thompson LDR; Magliocca KR; Andreasen S; Kiss K; Rooper L; Stelow E; Wenig BM; Bishop JA
Head Neck Pathol; 2019 Sep; 13(3):355-363. PubMed ID: 30291511
[TBL] [Abstract][Full Text] [Related]
56. A Clinicopathologic and Molecular Analysis of Fumarate Hydratase-deficient Renal Cell Carcinoma in 32 Patients.
Lau HD; Chan E; Fan AC; Kunder CA; Williamson SR; Zhou M; Idrees MT; Maclean FM; Gill AJ; Kao CS
Am J Surg Pathol; 2020 Jan; 44(1):98-110. PubMed ID: 31524643
[TBL] [Abstract][Full Text] [Related]
57. Renal cell carcinoma in patients with end-stage renal disease: relationship between histological type and duration of dialysis.
Nouh MA; Kuroda N; Yamashita M; Hayashida Y; Yano T; Minakuchi J; Taniguchi S; Nomura I; Inui M; Sugimoto M; Kakehi Y
BJU Int; 2010 Mar; 105(5):620-7. PubMed ID: 19747356
[TBL] [Abstract][Full Text] [Related]
58. Acquired Cystic Disease-associated Renal Cell Carcinoma (ACKD-RCC)-like Cysts.
Sun Y; Argani P; Tickoo SK; Epstein JI
Am J Surg Pathol; 2018 Oct; 42(10):1396-1401. PubMed ID: 30001236
[TBL] [Abstract][Full Text] [Related]
59. [Clinicopathologic features and differential diagnosis of multilocular cystic renal cell carcinoma].
Zhang W; Li Y; Lu Q; Zhuang J; Wang Q; Zhao H; Yu W; Kang E; Feng Z
Zhonghua Bing Li Xue Za Zhi; 2014 Nov; 43(11):723-7. PubMed ID: 25582248
[TBL] [Abstract][Full Text] [Related]
60. Renal cell carcinoma in dialysis patients: a single center experience.
Kojima Y; Takahara S; Miyake O; Nonomura N; Morimoto A; Mori H
Int J Urol; 2006 Aug; 13(8):1045-8. PubMed ID: 16903927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
